2m 2m 2m 2m 2m 2m 2m
Vanda Pharma (VNDA)
NASDAQ
$6.08-$0.010 (-0.16%)
Price as of Jun 03, 2026 7:28 PM EDT- $387.9MMarket Cap
- 39.64%1-Year Change
- BiotechnologyIndustry
Vanda Pharma (VNDA)
$6.08-$0.010 (-0.16%)
VNDA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $6.09 | ||
Change | -$0.23 (-3.69%) | ||
Open | $6.16 | ||
High | $6.19 | ||
Low | $6.02 | ||
Previous Close | $6.13 | ||
Volume | 812,920 | ||
30-Day Average Volume | 1,168,933 | ||
1-Week Change | -1.45% | ||
1-Month Change | -12.43% | ||
1-Year Change | 39.64% | ||
3-Year Change | 1.16% | ||
5-Year Change | -65.41% | ||
Fundamentals | |||
Shares Outstanding | 60.1M | ||
Total Assets | $433.5M | ||
Market Cap | $387.9M | ||
Enterprise Value | $333.8M | ||
Period: QTR TTM FY | |||
Revenue | $51.7M | ||
Net Income | -$48.6M | ||
Free Cash Flow | -$50.4M | ||
EBIT | -$48.4M | ||
EBITDA | -$46.4M | ||
Net Working Capital | $157.6M | ||
EPS | -$0.82 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 6 | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | -0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue